Annual ROE
-475.31%
-212.31%-80.73%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual return on equity is -475.31%, with the most recent change of -212.31% (-80.73%) on December 31, 2023.
- During the last 3 years, INBX annual ROE has fallen by -374.45% (-371.26%).
- INBX annual ROE is now -803.43% below its all-time high of 67.57%, reached on December 31, 2017.
Performance
INBX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
1854.62%
-761.84%-29.12%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly return on equity is 1854.62%, with the most recent change of -761.84% (-29.12%) on September 30, 2024.
- Over the past year, INBX quarterly ROE has dropped by -761.84% (-29.12%).
- INBX quarterly ROE is now -29.12% below its all-time high of 2616.46%, reached on June 30, 2024.
Performance
INBX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
INBX ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -80.7% | -29.1% |
3 y3 years | -371.3% | +237.9% |
5 y5 years | -979.2% | +237.9% |
INBX ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -271.6% | at low | -29.1% | +118.1% |
5 y | 5-year | -965.3% | at low | -29.1% | +118.1% |
alltime | all time | -803.4% | at low | -29.1% | +118.1% |
Inhibrx Biosciences ROE History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | 1854.62%(-29.1%) |
Jun 2024 | - | 2616.46%(-462.3%) |
Mar 2024 | - | -722.09%(+32.5%) |
Dec 2023 | -475.31%(+80.7%) | -544.89%(-17.4%) |
Sep 2023 | - | -660.05%(-93.6%) |
Jun 2023 | - | -10.24 K%(+661.8%) |
Mar 2023 | - | -1344.67%(+81.1%) |
Dec 2022 | -263.00%(+105.6%) | -742.33%(-19.6%) |
Sep 2022 | - | -923.32%(+145.6%) |
Jun 2022 | - | -375.87%(+70.7%) |
Mar 2022 | - | -220.19%(+40.6%) |
Dec 2021 | -127.91% | -156.66%(+20.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | -130.24%(-15.7%) |
Jun 2021 | - | -154.52%(-52.8%) |
Mar 2021 | - | -327.53%(+112.2%) |
Dec 2020 | -100.86%(-283.6%) | -154.35%(-114.5%) |
Sep 2020 | - | 1064.03%(+706.2%) |
Jun 2020 | - | 131.98%(+49.1%) |
Mar 2020 | - | 88.53%(+22.5%) |
Dec 2019 | 54.93%(+1.6%) | 72.26%(+23.4%) |
Sep 2019 | - | 58.58%(+135.1%) |
Jun 2019 | - | 24.92%(+37.2%) |
Mar 2019 | - | 18.16% |
Dec 2018 | 54.06%(-20.0%) | - |
Dec 2017 | 67.57% | - |
FAQ
- What is Inhibrx Biosciences annual return on equity?
- What is the all time high annual ROE for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual ROE year-on-year change?
- What is Inhibrx Biosciences quarterly return on equity?
- What is the all time high quarterly ROE for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly ROE year-on-year change?
What is Inhibrx Biosciences annual return on equity?
The current annual ROE of INBX is -475.31%
What is the all time high annual ROE for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual return on equity is 67.57%
What is Inhibrx Biosciences annual ROE year-on-year change?
Over the past year, INBX annual return on equity has changed by -212.31% (-80.73%)
What is Inhibrx Biosciences quarterly return on equity?
The current quarterly ROE of INBX is 1854.62%
What is the all time high quarterly ROE for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly return on equity is 2616.46%
What is Inhibrx Biosciences quarterly ROE year-on-year change?
Over the past year, INBX quarterly return on equity has changed by -761.84% (-29.12%)